Abstract Body

Elite controllers (ECs), maintain undetectable plasma virus levels in the absence of antiretroviral therapy, and serve as a model for cure of HIV-1 infection. Cytotoxic T lymphocytes (CTL) are widely recognized as the immune correlate most closely associated with an elite controller phenotype, but the frequency of CTL-driven mutations in intact proviral sequences from such individuals is unknown.

Single-genome near full-length proviral sequencing was used to analyze the proviral reservoir in 49 untreated ECs with undetectable viral loads for 1-20 years and in 28 HIV-1 patients treated with ART for 2-19 years. Optimal epitopes and escape mutations associated each person’s HLA-A, -B, and -C alleles were obtained from the Los Alamos HIV Immunology Database. Integration sites of intact proviruses were analyzed by Matched Integration Site and Proviral Sequencing (MIP-Seq) assays.

We obtained 199 and 89 near full-length intact proviral genomes from ECs and ART-treated individuals. A median of 47 optimal epitopes corresponding to expressed HLA Class I alleles were analyzed in ECs, compared to 49 in ART-treated individuals. Frequencies of CTL epitopes matching the clade B consensus sequence were higher in ECs relative to ART-treated patients (47.4% vs 37.9%, p=0.0005). Moreover, the proportion of CTL epitopes displaying known escape mutations was lower in ECs than in ART-treated individuals but did not reach statistical significance (5.67% vs 7.32%, p=0.2818). Among individuals carrying the protective HLA-B*27 and B*57 alleles, optimal epitopes from EC were more likely to show wild-type sequences (43.5% vs 30.4%, p=0.0013), and less likely to encompass previously defined CTL escape mutations (5.84% vs 17.4%, p=0.0043). Notably, among ECs, intact proviral sequences integrated in centromeric satellite DNA and non-genic DNA tended to exhibit lower frequencies of defined CTL escape mutations, compared to the intact proviral sequences integrated in non-centromeric DNA (p=0.0245) or genic regions (p=0.0254).

EC exhibit low frequencies of CTL escape-associated mutations in intact proviruses, despite the absence of antiretroviral therapy, suggesting either lack of viral replication or effective targeting of mutationally intolerant epitopes. The low proportion of CTL escape mutations in intact proviruses integrated in non-genic/centromeric DNA suggests that these sequences were seeded during early disease stages and are among the most ancestral proviruses in a given patient.